Imberti, Jacopo Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.399
NA - Nord America 4.314
EU - Europa 2.063
SA - Sud America 765
OC - Oceania 250
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.866
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.205
CN - Cina 1.693
SG - Singapore 1.283
BR - Brasile 640
HK - Hong Kong 633
IT - Italia 631
GB - Regno Unito 327
VN - Vietnam 263
AU - Australia 248
SE - Svezia 226
DE - Germania 219
KR - Corea 186
RU - Federazione Russa 184
FI - Finlandia 141
ID - Indonesia 85
AR - Argentina 58
FR - Francia 55
NL - Olanda 48
MX - Messico 47
CA - Canada 46
IN - India 44
AT - Austria 33
BD - Bangladesh 30
BG - Bulgaria 30
TR - Turchia 30
ZA - Sudafrica 29
LT - Lituania 27
PL - Polonia 25
IQ - Iraq 23
JP - Giappone 22
EC - Ecuador 17
ES - Italia 17
UA - Ucraina 17
AE - Emirati Arabi Uniti 12
CO - Colombia 12
EG - Egitto 12
PK - Pakistan 12
IE - Irlanda 11
KE - Kenya 11
VE - Venezuela 11
RS - Serbia 10
BE - Belgio 9
MA - Marocco 9
PY - Paraguay 9
RO - Romania 9
TH - Thailandia 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
HU - Ungheria 7
SA - Arabia Saudita 7
JO - Giordania 6
MY - Malesia 6
PE - Perù 6
TW - Taiwan 6
CL - Cile 5
CU - Cuba 5
DZ - Algeria 5
IR - Iran 5
KZ - Kazakistan 5
CH - Svizzera 4
GE - Georgia 4
IL - Israele 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
BY - Bielorussia 3
LU - Lussemburgo 3
PT - Portogallo 3
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
JM - Giamaica 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CY - Cipro 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
NI - Nicaragua 1
PA - Panama 1
SY - Repubblica araba siriana 1
Totale 11.864
Salva come PNG Salva come JPEG
Città #
Hefei 930
Santa Clara 918
Singapore 829
Hong Kong 632
Ashburn 527
Fairfield 236
Chandler 220
London 205
Beijing 187
Seoul 186
Nyköping 180
Perth 167
New York 146
Los Angeles 121
Chicago 100
Ho Chi Minh City 99
Helsinki 95
Woodbridge 95
Houston 93
Munich 90
Dallas 82
The Dalles 82
Seattle 79
Wilmington 77
Cambridge 71
Bologna 67
Jakarta 65
São Paulo 64
Shanghai 61
Milan 58
Kent 52
Buffalo 51
Hanoi 51
Moscow 49
San Diego 47
Modena 41
Rome 41
Sydney 38
Princeton 37
Ann Arbor 34
Mexico City 30
Salt Lake City 29
Sofia 29
Lappeenranta 27
Southend 25
Redondo Beach 23
Nuremberg 20
Orem 20
Tokyo 20
Amsterdam 19
Atlanta 19
Johannesburg 19
Turku 19
Parma 18
Vienna 18
Düsseldorf 17
Frankfurt am Main 17
Guangzhou 17
Toronto 17
Turin 17
Warsaw 17
Portsmouth 16
Stockholm 16
Kilburn 15
Campinas 14
Elk Grove Village 14
Haiphong 14
Rio de Janeiro 14
Belo Horizonte 13
Columbus 13
Denver 13
Porto Alegre 13
Tampa 13
Boston 12
Brooklyn 12
Melbourne 12
Poplar 12
Ankara 11
Brasília 11
Dublin 11
Montreal 11
Phoenix 11
Biên Hòa 10
Boardman 10
Curitiba 10
Lauterbourg 10
Miami 10
Naples 10
Reggio Emilia 10
Baghdad 9
Da Nang 9
Jacksonville 9
Perugia 9
Ribeirão Preto 9
Baku 8
Belgrade 8
Brussels 8
Carpi 8
Des Moines 8
Nairobi 8
Totale 8.074
Salva come PNG Salva come JPEG
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 438
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) 269
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 237
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 217
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 198
Remote monitoring and telemedicine in heart failure: implementation and benefits 179
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 177
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 172
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 172
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 167
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 166
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 164
What do we do about atrial high rate episodes? 162
Female sex and stroke in atrial fibrillation: an intriguing relationship 161
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 157
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 147
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 138
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 138
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 137
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 135
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 134
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 134
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 132
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 132
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 131
Atrial fibrillation burden: Stepping beyond the categorical characterization 130
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 130
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 129
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 127
Atrial fibrillation in pneumonia: what clinical implications at long-term? 127
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 125
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 125
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 124
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 124
Single-lead VDD pacing: a literature review on short-term and long-term performance 122
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 122
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 122
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 119
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 118
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 118
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 116
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 115
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 112
Clinical decisions for appropriate management of patients with atrial fibrillation 111
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 109
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 108
Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing 106
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 106
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 104
Inhibition of lysyl oxidase stimulates TGF-β signaling and metalloproteinases-2 and -9 expression and contributes to the disruption of ascending aorta in rats: protection by propylthiouracil 104
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 103
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 103
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation 102
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 101
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: A systematic review and meta-analysis 101
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe 100
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 100
Clinical significance and prognostic value of right bundle branch block in permanent pacemaker patients 97
Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation 95
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation 95
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 94
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 94
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 93
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 93
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling 91
Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry 91
Antiarrhythmic drugs in the era of atrial fibrillation ablation 88
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 88
Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations? 88
Screening for atrial fibrillation: different approaches targeted to reduce ischemic stroke 87
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 86
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: Let's talk about sex 85
Echocardiographic Left Ventricular Mass Assessment: Correlation between 2D-Derived Linear Dimensions and 3-Dimensional Automated, Machine Learning-Based Methods in Unselected Patients 82
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 82
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 81
The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy 79
Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction 78
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 76
The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome 75
Letter by Imberti et al Regarding Article, "DREAM-ICD-II Study" 75
Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)? 75
Length of hospital stay for elective electrophysiological procedures: a survey from the European Heart Rhythm Association 74
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 73
The epidemiology and mortality of patients with atrial fibrillation: a complex landscape 73
Progression of Atrial Fibrillation after Cryoablation 73
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry 73
Mobile health technology in atrial fibrillation 71
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 70
Access to implantable cardioverter defibrillator therapy within and across countries: the barriers still persist 69
Remote monitoring of cardiac implantable electronic devices: from data to clinical actions 69
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 68
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry 68
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients 66
Atrial fibrillation screening: The importance of the patient perspective 65
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long odyssey? 64
New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development 64
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 63
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry 61
Economic Evaluations in Electrophysiology in the Last 15 Years: A Systematic Review of the Literature 54
Validation of a multiple‑lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy 54
Totale 11.397
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.007
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021414 0 0 0 0 0 12 188 85 36 42 24 27
2021/2022667 52 76 14 24 25 43 18 38 68 42 126 141
2022/2023835 88 92 81 50 64 110 29 90 94 19 73 45
2023/20241.088 18 55 67 110 240 141 88 132 18 37 57 125
2024/20254.367 74 58 264 230 616 564 407 263 420 285 633 553
2025/20264.486 679 430 805 1.133 995 444 0 0 0 0 0 0
Totale 12.021